News Regeneron is off to CHAPLE as FDA starts pozelimab review The C5 inhibitor is vying to become the first approved drug for the ultra-rare immune disorder.
News As pandemic abates, NICE issues new COVID drug guidance NICE says it is the first HTA to give guidance on the drugs outside of use during the pandemic.
News CSL’s Hemgenix is first haemophilia B gene therapy in EU Firm will work with payers to try to secure access for as many patients across EU as possible.
News Travere undercuts key rival in rare kidney disease IgAN Filspari will launch for IgA Nepropathy at a discount to Calliditas' Tarpeyo, cleared in 2021.
News FDA undoes Astellas’ bid for fast review of menopause drug Pharma company had used a priority review voucher to speed up review of fezolinetant.
News Apellis breaks new ground in geographic atrophy Syfovre is the first FDA-approved drug for GA, which damages the sight of 5m people worldwide.
News Simple blood test could aid in global TB fight A blood test for tuberculosis that can distinguish between dormant and active infections has shown promise in a clinical trial.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
